Hims & Hers Health Inc (NYSE: HIMS) isn't just chasing wellness trends — it's building a global health platform. At the ...

Between 30 million and 50 million men in the US have erectile dysfunction, including a staggering 70% of men over 70.

Earnings Rewind: AMD, Uber, & Hims Bet on the Future as Robinhood & DraftKings Shock Wall Street Time In the Market Record ...

Investors with an interest in Schools stocks have likely encountered both Perdoceo Education (PRDO) and New Oriental ...

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

AGCO Corp. renewed its headquarters at 4205 River Green Parkway, a two-story, 125,800 SF office building in Duluth, a ...

Chegg, Inc. CHGG is scheduled to report its third-quarter 2025 results on Nov. 10, after market close.In the last reported ...

Risky assets slid, with tech stocks and cryptocurrencies bearing the brunt of the selling, after long-simmering concerns ...

Hims & Hers Health (HIMS) stock rises as the company renews talks with Novo Nordisk (NVO) to sell the pharma giant's obesity drug Wegovy. Read more here.

(Reuters) -Hims and Hers Health missed Wall Street estimates for third-quarter profit on Monday, hit by increased product costs and reduced unit sales in the telehealth company's weight-loss business.

In the medical admission fraud case, a group of fraudsters posing as medical admission consultants duped four people of Rs ...

Current costs for people without insurance are closer to $500 per month at the higher doses. The drugmakers also pledged to ...